IBO vs PEG · rev $18.0K vs P/E 18, rev $10.29B
Impact BioMedical, Inc. (IBO) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
IBO currently screens at market cap $7.6M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the IBO and PEG stock pages for the full models.
Not investment advice.